Conjunctivitis [clinicaltrials_resource:a1c138e5a54ac7b3dda266d5f78d6d7a]
Screening for NEI Clinical Studies [clinicaltrials:NCT00001734]Evaluation and Treatment of Patients With Corneal and External Diseases [clinicaltrials:NCT00008541]Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations [clinicaltrials:NCT00522600]clinicaltrials:NCT00550550clinicaltrials:NCT00562159Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [clinicaltrials:NCT00567762]Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [clinicaltrials:NCT00567918]Moxifloxacin vs. Polytrim for Conjunctivitis [clinicaltrials:NCT00581542]Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation [clinicaltrials:NCT00623701]clinicaltrials:NCT00705159clinicaltrials:NCT00732446clinicaltrials:NCT00770315clinicaltrials:NCT00783198Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients [clinicaltrials:NCT00857779]clinicaltrials:NCT00921895clinicaltrials:NCT00978029clinicaltrials:NCT01028027clinicaltrials:NCT01385371Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus [clinicaltrials:NCT01600365]clinicaltrials:NCT02472223Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients [clinicaltrials:NCT02503956]
condition [clinicaltrials_vocabulary:condition]
Screening for NEI Clinical Studies [clinicaltrials:NCT00001734]Evaluation and Treatment of Patients With Corneal and External Diseases [clinicaltrials:NCT00008541]clinicaltrials:NCT00105469clinicaltrials:NCT00105534Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis [clinicaltrials:NCT00133627]Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers [clinicaltrials:NCT00223951]Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis [clinicaltrials:NCT00241319]Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis [clinicaltrials:NCT00244543]Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears [clinicaltrials:NCT00266734]Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan [clinicaltrials:NCT00276445]Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 [clinicaltrials:NCT00298337]A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) [clinicaltrials:NCT00311844]clinicaltrials:NCT00312338Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) [clinicaltrials:NCT00328653]Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis [clinicaltrials:NCT00331500]AL-15469A for the Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT00331916]AL-15469A for the Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT00332293]clinicaltrials:NCT00347932clinicaltrials:NCT00348348Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis [clinicaltrials:NCT00357773]Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis [clinicaltrials:NCT00364091]A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis [clinicaltrials:NCT00375596]Mast-Cell Stabilizing Effects of Olopatadine [clinicaltrials:NCT00389025]Systemic Pharmacokinetics of BOL-303224-A [clinicaltrials:NCT00407589]Normal Values of Facial Thermography [clinicaltrials:NCT00411606]Twin SUBLIVAC® Grasses Clinical Efficacy Study [clinicaltrials:NCT00422149]Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis [clinicaltrials:NCT00423007]clinicaltrials:NCT00424398Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis [clinicaltrials:NCT00432757]Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study [clinicaltrials:NCT00443105]Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis [clinicaltrials:NCT00445874]clinicaltrials:NCT00464438Comparison of CL Wear Between Two Allergy Drops [clinicaltrials:NCT00489398]Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense [clinicaltrials:NCT00501527]clinicaltrials:NCT00509873clinicaltrials:NCT00518089Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations [clinicaltrials:NCT00522600]clinicaltrials:NCT00534794Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) [clinicaltrials:NCT00537342]clinicaltrials:NCT00540631
condition browse [clinicaltrials_vocabulary:condition-browse]
Screening for NEI Clinical Studies [clinicaltrials:NCT00001734]Evaluation and Treatment of Patients With Corneal and External Diseases [clinicaltrials:NCT00008541]clinicaltrials:NCT00105469clinicaltrials:NCT00105534Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis [clinicaltrials:NCT00133627]Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers [clinicaltrials:NCT00223951]Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis [clinicaltrials:NCT00241319]Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis [clinicaltrials:NCT00244543]Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears [clinicaltrials:NCT00266734]Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan [clinicaltrials:NCT00276445]Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 [clinicaltrials:NCT00298337]A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) [clinicaltrials:NCT00311844]clinicaltrials:NCT00312338Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) [clinicaltrials:NCT00328653]Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis [clinicaltrials:NCT00331500]AL-15469A for the Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT00331916]AL-15469A for the Treatment of Bacterial Conjunctivitis [clinicaltrials:NCT00332293]clinicaltrials:NCT00347932clinicaltrials:NCT00348348Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis [clinicaltrials:NCT00357773]Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis [clinicaltrials:NCT00364091]A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis [clinicaltrials:NCT00375596]Mast-Cell Stabilizing Effects of Olopatadine [clinicaltrials:NCT00389025]Systemic Pharmacokinetics of BOL-303224-A [clinicaltrials:NCT00407589]Normal Values of Facial Thermography [clinicaltrials:NCT00411606]Twin SUBLIVAC® Grasses Clinical Efficacy Study [clinicaltrials:NCT00422149]Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis [clinicaltrials:NCT00423007]clinicaltrials:NCT00424398Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis [clinicaltrials:NCT00432757]Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study [clinicaltrials:NCT00443105]Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis [clinicaltrials:NCT00445874]clinicaltrials:NCT00464438Comparison of CL Wear Between Two Allergy Drops [clinicaltrials:NCT00489398]Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense [clinicaltrials:NCT00501527]clinicaltrials:NCT00509873clinicaltrials:NCT00518089Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations [clinicaltrials:NCT00522600]clinicaltrials:NCT00534794Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) [clinicaltrials:NCT00537342]clinicaltrials:NCT00540631
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Conjunctivitis [clinicaltrials_resource:a1c138e5a54ac7b3dda266d5f78d6d7a]
Bio2RDF identifier
a1c138e5a54ac7b3dda266d5f78d6d7a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a1c138e5a54ac7b3dda266d5f78d6d7a
identifier
clinicaltrials_resource:a1c138e5a54ac7b3dda266d5f78d6d7a
title
Conjunctivitis
@en
type
label
Conjunctivitis [clinicaltrials_resource:a1c138e5a54ac7b3dda266d5f78d6d7a]
@en
Conjunctivitis